Toshiaki et al. used CLEC-2-deficient mice to show that CLEC-2 deficiency may suppress thrombus formation in tumour vessels in the lungs and subsequently inhibit systemic inflammation and cachexia [19]. This evidence concerns the gene CLEC1B and neoplasm.